Trial site
London
- 15running trials
- 10closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis9 trials
- High blood pressure4 trials
- Chronic kidney disease2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Alzheimer disease1 trial
- Childhood cancers1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Huntington's disease1 trial
- Lichen planus1 trial
- Prostate cancer1 trial
- Sarcoidosis1 trial
- Phase
- Phase 311 trials
- Phase 16 trials
- Phase 25 trials
- Phase 2/33 trials
- Status
- Recruiting9 trials
- Completed8 trials
- Active, not recruiting4 trials
- Enrolling by invitation2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Alnylam Pharmaceuticals15 trials
- Priovant Therapeutics, Inc.3 trials
- Intellia Therapeutics2 trials
- Olema Pharmaceuticals, Inc.2 trials
- Arvinas Androgen Receptor, Inc.1 trial
- and 2 more
Running trials
Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Recruiting
Recruiting
Recruiting
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Enrolling by invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Recruiting
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Active, not recruiting
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Active, not recruiting
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis4 recruiting
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Childhood cancers1 recruiting
- High blood pressure1 recruiting
- Huntington's disease1 recruiting
- Lichen planus1 recruiting
- Metastatic breast cancer1 recruiting
- Sarcoidosis1 recruiting
Closed trials
Completed
Completed
Completed
Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer
Completed
Completed
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Recruiting
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026